Evidence map›Paper›PMID 40115656›Full record

ArticleGastroenterology & hepatology2025

Optimal Approach to Colorectal Cancer Screening.

Christina Wang, Aasma Shaukat

Abstract read
In one paragraph

Article in Gastroenterology & hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Christina WangDivision of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Aasma ShaukatDivision of Gastroenterology, Department of Medicine, New York University Grossman School of Medicine and the VA New York Harbor Health Care, New York, New York.

Funding

Chi gung: a community-based strategy in Chinese immigrant women to improve colorectal and breast cancer screening.K08CA283362 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Christina Wang · 2024 to 2026
$576k
NCI NIH HHS K08 CA283362
6 · The paper itself

Abstract

Rates of colorectal cancer (CRC) screening in the United States continue to fall short of guideline-recommended benchmarks. Challenges to increasing CRC screening include racial disparities, barriers at multiple levels of the health care system, and inadequate completion of 2-step screening. With new options for CRC screening and employment of programmatic strategies for screening by physicians, patients will have more opportunities to initiate and complete testing, which can ultimately improve CRC detection and prevention. This article highlights the current state of and optimal approach to CRC screening.

Indexed as

colonoscopyColorectal cancerscreening modalitiesstool-based tests

Identifiers

PMID40115656
PMCPMC11920019

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.